Orgenesis
Pall Corporation
Orgenesis (Israel) collaborated with Pall Corporation (Port Washington, NY) to develop a cell therapy treatment for patients who have diabetes.
In this process, the patient’s cells are harvested and transdifferentiated in bioreactors into functional insulin-producing cells and then transplanted back into the patient to function and produce the insulin needed to regulate the patient’s blood sugar. The technology, supported by the BIRD Foundation, dramatically reduces the investment required to set up a production facility for this treatment and potentially makes it accessible in every cell therapy medical center. Johns Hopkins Hospital (Maryland) uses this innovative technology in its newly built Cell Therapy facility to treat diabetic patients.
Approved 2015
